| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Epitinib succinate |
琥珀酸EPITINIB |
2252334-12-4 |
詳細(xì)
|
| CMP-5 2HCl |
化合物CMP-5鹽酸鹽 |
2309409-79-6 |
詳細(xì)
|
| 2,6-Dibromo-4-(hydroxymethyl)phenol |
2,6-二溴-4-(羥甲基)苯酚 |
2316-62-3 |
詳細(xì)
|
| MARK4 inhibitor 1 |
MARK4 inhibitor 1 |
2271081-58-2 |
詳細(xì)
|
| M2N12 |
M2N12 |
2376577-06-7 |
詳細(xì)
|
| IRE1α kinase-IN-1 |
化合物IRE1Α KINASE-IN-1 |
2328097-41-0 |
詳細(xì)
|
| NF-κΒ activator 1 |
化合物NF-ΚΒ ACTIVATOR 1 |
2387524-59-4 |
詳細(xì)
|
| UMB298 |
UMB298 |
2266569-73-5 |
詳細(xì)
|
| KB-0742 dihydrochloride |
KB-0742 dihydrochloride |
2416874-75-2 |
詳細(xì)
|
| AHR antagonist 5 free base |
化合物AHR ANTAGONIST 5 FREE BASE |
2247950-42-9 |
詳細(xì)
|
| ACSS2-IN-2 |
化合物ACSS2-IN-2 |
2332820-04-7 |
詳細(xì)
|
| AAPK-25 |
AAPK-25 |
2247919-28-2 |
詳細(xì)
|
| XL177A |
化合物XL177A |
2417089-74-6 |
詳細(xì)
|
| BAY 2666605 |
化合物BAY 2666605 |
2275774-60-0 |
詳細(xì)
|
| BRM/BRG1 ATP Inhibitor-2 |
化合物 BRM/BRG1 ATP INHIBITOR-2 |
2368900-77-8 |
詳細(xì)
|
| BCL6-IN-6 |
化合物BCL6-IN-6 |
2408882-54-0 |
詳細(xì)
|
| Auristatin23 |
((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-2-((S)-2-((4-((叔丁氧羰基)(甲基)氨基)丁基)(甲基)胺)-3-甲基丁酰胺)-N,3-二甲基丁酰胺基)-3-甲氧基-5-甲基庚?；?吡咯烷-2-基)-3-乙氧基-2-甲基丙?；?-L-苯丙氨酸 |
2375388-36-4 |
詳細(xì)
|
| PD-1-IN-22 |
PD-1-IN-22 |
2349372-98-9 |
詳細(xì)
|
| CRT0066854 hydrochloride |
CRT0066854 hydrochloride |
2250019-91-9 |
詳細(xì)
|
| DS08210767 |
DS08210767 |
2376334-75-5 |
詳細(xì)
|
| 2-((2,2-Dibenzylhydrazineylidene)methyl)pyridine |
2-Pyridinecarboxaldehyde, 2,2-bis(phenylmethyl)hydrazone |
237402-29-8 |
詳細(xì)
|
| TRPV4 agonist-1 free base |
4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)- |
2314467-59-7 |
詳細(xì)
|
| WSB1 Degrader 1 |
化合物WSB1 DEGRADER 1 |
2306039-66-5 |
詳細(xì)
|
| Sivopixant |
S-600918 |
2414285-40-6 |
詳細(xì)
|
| TH5427 |
TH 5427 |
2253744-56-6 |
詳細(xì)
|
| AGI-43192 |
化合物AGI-43192 |
2377491-54-6 |
詳細(xì)
|
| Tubulin inhibitor 24 |
化合物TUBULIN INHIBITOR 24 |
2415761-65-6 |
詳細(xì)
|
| Compound 227105-11-5 |
4-芐氧基肉桂酸 |
227105-11-5 |
詳細(xì)
|
| Antitumor agent-19 |
Antitumor agent-19 |
2379727-90-7 |
詳細(xì)
|
| ms48107 |
化合物MS48107 |
2375070-79-2 |
詳細(xì)
|
| LY3405105 |
1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester |
2326428-25-3 |
詳細(xì)
|
| Msr-Ratio |
MSR-RATIO |
2290635-22-0 |
詳細(xì)
|
| Mito-LND |
化合物MITO-LND |
2361564-49-8 |
詳細(xì)
|
| HeE1-2Tyr |
化合物HEE1-2TYR |
2245195-67-7 |
詳細(xì)
|
| BOS-318 |
化合物BOS-318 |
2387633-15-8 |
詳細(xì)
|
| DS12881479 |
化合物DS12881479 |
2373065-59-7 |
詳細(xì)
|
| K-Ras G12C-IN-4 |
K-RAS G12C-IN-4 |
2376328-55-9 |
詳細(xì)
|
| anti-TB agent 1 |
anti-TB agent 1 |
2294013-78-6 |
詳細(xì)
|
| Hamaline |
Hamaline |
2411677-02-4 |
詳細(xì)
|
| cis VH 032, amine dihydrochloride |
CIS VH 032, AMINE DIHYDROCHLORIDE |
2376990-32-6 |
詳細(xì)
|
| WEE1-IN-3 |
JUN76288 |
2272976-28-8 |
詳細(xì)
|
| CVN424 |
Ethanone, 1-[2-[4-(2,4-difluorophenoxy)-1-piperidinyl]-7,8-dihydro-3-[[(3R)-tetrahydro-3-furanyl]amino]pyrido[3,4-b]pyrazin-6(5H)-yl]- |
2254706-21-1 |
詳細(xì)
|
| HM43239 |
化合物HM43239 |
2294874-49-8 |
詳細(xì)
|
| MERS-CoV-IN-1 |
化合物MERS-COV-IN-1 |
2245697-92-9 |
詳細(xì)
|
| SU056 |
化合物SU056 |
2376580-08-2 |
詳細(xì)
|
| nerolidol acetate |
3,7,11-三甲基-1,6,10-十二烷三烯-3-醇乙酸酯 |
2306-78-7 |
詳細(xì)
|
| CHMFL-PI3KD-317 |
CHMFL-PI3KD-317 |
2244992-76-3 |
詳細(xì)
|
| Thalidomide-O-amido-C6-NH2 hydrochloride |
Thalidomide-linker 15 |
2376990-31-5 |
詳細(xì)
|
| BuChE-IN-TM-10 |
TM-10 |
2313524-95-5 |
詳細(xì)
|
| C/EBPα inducer 1 |
化合物T8871 |
2374285-52-4 |
詳細(xì)
|
| visamminol-3'-O- glucoside |
維斯阿米醇-3'-O-葡萄糖苷 |
2254096-98-3 |
詳細(xì)
|
| (S)-ErSO |
化合物(S)-ERSO |
2407860-34-6 |
詳細(xì)
|
| 1-(2-hydroxyethyl)thymine |
1-(2-羥基乙基)-5-甲基-1,2,3,4-四氫嘧啶-2,4-二酮 |
22441-51-6 |
詳細(xì)
|
| SGC-AAK1-1 |
AAK1 inhibitor 1 |
2247894-32-0 |
詳細(xì)
|
| Nampt-IN-5 |
化合物NAMPT-IN-5 |
2380013-17-0 |
詳細(xì)
|
| PDE9-IN-1 |
PDE9-IN-1 |
2305087-92-5 |
詳細(xì)
|
| Reverse transcriptase-IN-1 |
Reverse transcriptase-IN-1 |
2380001-43-2 |
詳細(xì)
|
| CDK12-IN-2 |
化合物CDK12-IN-2 |
2244987-03-7 |
詳細(xì)
|
| RBN-3143 |
PARP14抑制劑 |
2360853-16-1 |
詳細(xì)
|
| SRI-37330 |
化合物SRI-37330 |
2322245-42-9 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG2-NH2 dihydrochloride |
VH 032-linker 12 |
2341796-76-5 |
詳細(xì)
|
| Enbezotinib |
TPX-0046 |
2359649-81-1 |
詳細(xì)
|
| SET 2 |
SET 2 |
2313525-20-9 |
詳細(xì)
|
| LMPTP INHIBITOR 1 hydrochloride |
化合物L(fēng)MPTP INHIBITOR 1 HYDROCHLORIDE |
2310135-38-5 |
詳細(xì)
|
| CRT0066101 dihydrochloride(956121-30-5 free base) |
化合物CRT0066101 DIHYDROCHLORIDE |
2308510-39-4 |
詳細(xì)
|
| FLT3-IN-4 |
FLT3-IN-4 |
2304799-09-3 |
詳細(xì)
|
| AES-135 |
AES-135 |
2361659-61-0 |
詳細(xì)
|
| TD-165 |
TD-165 |
2305936-56-3 |
詳細(xì)
|
| CWHM-1552 |
CWHM-1552 |
2368253-58-9 |
詳細(xì)
|
| dBRD9 HCl |
DBRD9 HCL(2170679-45-3 FREE BASE) |
2341840-98-8 |
詳細(xì)
|
| Thalidomide-5-NH2-CH2-COOH |
化合物T40019 |
2412056-27-8 |
詳細(xì)
|
| 2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}acetic acid |
2,2,2-trifluoroacetic acid |
2377032-39-6 |
詳細(xì)
|
| 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(7-(1-methyl-1H-pyrazol-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl)urea |
化合物T60124 |
2379727-88-3 |
詳細(xì)
|
| F-1 |
F-1 |
2244775-31-1 |
詳細(xì)
|
| SHIP2-IN-1 |
SHIP2-IN-1 |
2252247-80-4 |
詳細(xì)
|
| Thalidomide-O-C4-NH2 hydrochloride |
Thalidomide-linker 9 |
2376990-29-1 |
詳細(xì)
|
| IMT1 |
化合物L(fēng)DC195943(IMT1) |
2304621-31-4 |
詳細(xì)
|
| HS271 |
化合物HS271 |
2410393-15-4 |
詳細(xì)
|
| PLN-1474 |
PLN1474 |
2408065-32-5 |
詳細(xì)
|
| Proquazone |
普羅喹宗 |
22760-18-5 |
詳細(xì)
|
| IU1-248 |
Benzonitrile, 4-[3-[2-(4-hydroxy-1-piperidinyl)acetyl]-2,5-dimethyl-1H-pyrrol-1-yl]- |
2307472-03-1 |
詳細(xì)
|
| Compound TPX-0046 |
TPX-0046 |
2411115-73-4 |
詳細(xì)
|
| Pumecitinib |
化合物PUMECITINIB |
2401057-12-1 |
詳細(xì)
|
| CHIKV-IN-2 |
5H-Benzocycloheptene-2-carboxamide, N-[4-(1-cyano-1-methylethyl)phenyl]-6,7,8,9-tetrahydro-3-methoxy- |
2361289-44-1 |
詳細(xì)
|
| NAcM-OPT HCl(2089293-61-6 free base) |
化合物NACM-OPT HCL |
2416146-10-4 |
詳細(xì)
|
| BUR1 |
1-phenyl-4-piperidin-1-ylpyrazolo[3,4-d]pyrimidine |
23000-46-6 |
詳細(xì)
|
| UCM-1306 |
化合物UCM-1036 |
2258608-78-3 |
詳細(xì)
|
| 2H-Pyrido[2',1':3,4]pyrazino[1,2-b]indazole-3-carboxylic acid, 6-(1,1-dimethylethyl)-6,7-dihydro-10-(3-methoxypropoxy)-2-oxo-, (6R)- |
化合物 ANTIVIRAL AGENT 38 |
2247932-38-1 |
詳細(xì)
|
| SCR130 |
1,7,9-Triazaspiro[4.5]dec-1-ene-6,10-dione, 2,4-bis(4-chlorophenyl)-8-thioxo- |
2377858-38-1 |
詳細(xì)
|
| P2Y2R/GPR17 antagonist 1 |
P2Y2R/GPR17拮抗劑1 |
2395016-49-4 |
詳細(xì)
|
| (E)-1-[(E)-3-(4-hydroxy-3-methoxyphenyl)acryloyl]-3- (3,4,5-trimethoxybenzylidene) piperidin-2-one |
化合物 ANTI-INFLAMMATORY AGENT 36 |
2293951-01-4 |
詳細(xì)
|
| DDO-7263 |
化合物DDO-7263 |
2254004-96-9 |
詳細(xì)
|
| DC-TEADin02 |
化合物DC-TEADIN02 |
2380228-45-3 |
詳細(xì)
|
| ANT3310 |
ANT3310 |
2410688-61-6 |
詳細(xì)
|
| GA-017 |
化合物GA-017 |
2351906-74-4 |
詳細(xì)
|
| 5,6-Epoxyergosterol |
環(huán)氧麥角甾醇 |
23637-31-2 |
詳細(xì)
|
| 3-amino-1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one dihydrochloride |
化合物T50072 |
2411178-94-2 |
詳細(xì)
|
| ENFENAMIC ACID |
因法來酸 |
23049-93-6 |
詳細(xì)
|
| SN-008 |
化合物SN-008 |
2249106-01-0 |
詳細(xì)
|
| 2-Methoxy-4-{(E)-3-oxo-3-[(E)-2-oxo-3-(3,4,5- trimethoxybenzylidene)piperidin-1-yl]prop-1-en-1-yl}phenyl acetate |
化合物T64358 |
2293951-00-3 |
詳細(xì)
|